Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Nov, 2019 | Pages:
200 | Publisher: The Business Research Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Psoriasis Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global psoriasis drugs market. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order. Description: Where is the largest and fastest growing market for the psoriasis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Psoriasis Drugs Market Global Report from The Business Research Company answers all these questions and many more. The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. • The Market Characteristics section of the report defines and explains the market. • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market. • Market Segmentations break down market into sub markets. • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this. Scope Markets Covered: 1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor 2) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce 3) By Drug Types: Small molecules, Biologics �4) By Route Of Administration: Oral, Tropical, Injectable 5) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis Companies Mentioned: AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly and Company., Celgene Corporation Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa Time Series: Five years historic and forecast. Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary 2. Psoriasis Drugs Market Characteristics 3. Psoriasis Drugs Market Size And Growth 3.1. Global Psoriasis Drugs Historic Market, 2015 - 2019, $ Billion 3.1.1. Drivers Of The Market 3.1.2. Restraints On The Market 3.2. Global Psoriasis Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion 3.2.1. Drivers Of The Market 3.2.2. Restraints On the Market 4. Psoriasis Drugs Market Segmentation 4.1. Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Interleukin Inhibitors Corticosteroids Anti-Inflammatory Tumor Necrosis Factor Inhibitor 4.2. Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Hospitals Retail Pharmacies E-commerce 4.3. Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Small Molecules Biologics 4.4. Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Oral Tropical Injectable 4.5. Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Plaque Psoriasis Nail Psoriasis Guttate Psoriasis Pustular Psoriasis Erythrodermic Psoriasis 5. Psoriasis Drugs Market Regional And Country Analysis 5.1. Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 5.2. Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6. Asia-Pacific Psoriasis Drugs Market 6.1. Asia-Pacific Psoriasis Drugs Market Overview 6.2. Asia-Pacific Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6.3. Asia-Pacific Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 7. China Psoriasis Drugs Market 7.1. China Psoriasis Drugs Market Overview 7.2. China Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 7.3. China Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 8. India Psoriasis Drugs Market 8.1. India Psoriasis Drugs Market Overview 8.2. India Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 8.3. India Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9. Japan Psoriasis Drugs Market 9.1. Japan Psoriasis Drugs Market Overview 9.2. Japan Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9.3. Japan Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10. Australia Psoriasis Drugs Market 10.1. Australia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10.2. Australia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11. Indonesia Psoriasis Drugs Market 11.1. Indonesia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11.2. Indonesia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12. South Korea Psoriasis Drugs Market 12.1. South Korea Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12.2. South Korea Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13. Western Europe Psoriasis Drugs Market 13.1. Western Europe Psoriasis Drugs Market Overview 13.2. Western Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13.3. Western Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14. UK Psoriasis Drugs Market 14.1. UK Psoriasis Drugs Market Overview 14.2. UK Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14.3. UK Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15. Germany Psoriasis Drugs Market 15.1. Germany Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15.2. Germany Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16. France Psoriasis Drugs Market 16.4. France Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16.5. France Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17. Eastern Europe Psoriasis Drugs Market 17.1. Eastern Europe Psoriasis Drugs Market Overview 17.2. Eastern Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17.3. Eastern Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18. Russia Psoriasis Drugs Market 18.1. Russia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18.2. Russia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19. North America Psoriasis Drugs Market 19.1. North America Psoriasis Drugs Market Overview 19.2. North America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19.3. North America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20. USA Psoriasis Drugs Market 20.1. USA Psoriasis Drugs Market Overview 20.2. USA Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20.3. USA Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21. South America Psoriasis Drugs Market 21.1. South America Psoriasis Drugs Market Overview 21.2. South America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21.3. South America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22. Brazil Psoriasis Drugs Market 22.1. Brazil Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22.2. Brazil Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23. Middle East Psoriasis Drugs Market 23.1. Middle East Psoriasis Drugs Market Overview 23.2. Middle East Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23.3. Middle East Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24. Africa Psoriasis Drugs Market 24.1. Africa Psoriasis Drugs Market Overview 24.2. Africa Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24.3. Africa Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 25. Psoriasis Drugs Market Competitive Landscape And Company Profiles 25.1. Psoriasis Drugs Market Competitive Landscape 25.2. Psoriasis Drugs Market Company Profiles 25.2.1. AbbVie Inc. 25.2.1.1. Overview 25.2.1.2. Products and Services 25.2.1.3. Strategy 25.2.1.4. Financial Performance 25.2.2. Pfizer Inc. 25.2.2.1. Overview 25.2.2.2. Products and Services 25.2.2.3. Strategy 25.2.2.4. Financial Performance 25.2.3. Novartis 25.2.3.1. Overview 25.2.3.2. Products and Services 25.2.3.3. Strategy 25.2.3.4. Financial Performance 25.2.4. Eli Lilly and Company. 25.2.4.1. Overview 25.2.4.2. Products and Services 25.2.4.3. Strategy 25.2.4.4. Financial Performance 25.2.5. Celgene Corporation 25.2.5.1. Overview 25.2.5.2. Products and Services 25.2.5.3. Strategy 25.2.5.4. Financial Performance 26. Key Mergers And Acquisitions In The Psoriasis Drugs Market 27. Psoriasis Drugs Market Trends And Strategies 28. Product Pipeline Analysis 29. Psoriasis Drugs Market Future Outlook and Potential Analysis 30. Appendix 30.1. Abbreviations 30.2. Currencies 30.3. Research Inquiries 30.4. The Business Research Company 30.5. Copyright And Disclaimer
List of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Table 3: Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 4: Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 5: Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 6: Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 7: Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 8: Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 9: Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 10: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 11: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 12: China, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 13: China, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 14: India, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 15: India, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 16: Japan, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 17: Japan, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 18: Australia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 19: Australia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 20: Indonesia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 21: Indonesia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 22: South Korea, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 23: South Korea, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 24: Western Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 25: Western Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 26: UK, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 27: UK, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 28: Germany, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 29: Germany, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 30: France, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 31: France, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 32: Eastern Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 33: Eastern Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 34: Russia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 35: Russia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 36: North America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 37: North America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 38: USA, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 39: USA, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 40: South America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 41: South America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 42: Brazil, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 43: Brazil, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 44: Middle East, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 45: Middle East, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 46: Africa, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 47: Africa, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 48: AbbVie Inc. Financial Performance Table 49: Pfizer Inc. Financial Performance Table 50: Novartis Financial Performance Table 51: Eli Lilly and Company. Financial Performance Table 52: Celgene Corporation Financial Performance
List of Figures
Figure 1: Global Historic Market Growth, 2015-2019, $ Billion Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Figure 3: Global Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 4: Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 5: Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 6: Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 7: Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 8: Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 9: Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 10: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 11: Asia-Pacific, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 12: China, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 13: China, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 14: India, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 15: India, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 16: Japan, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 17: Japan, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 18: Australia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 19: Australia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 20: Indonesia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 21: Indonesia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 22: South Korea, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 23: South Korea, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 24: Western Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 25: Western Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 26: UK, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 27: UK, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 28: Germany, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 29: Germany, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 30: France, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 31: France, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 32: Eastern Europe, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 33: Eastern Europe, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 34: Russia, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 35: Russia, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 36: North America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 37: North America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 38: USA, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 39: USA, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 40: South America, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 41: South America, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 42: Brazil, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 43: Brazil, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 44: Middle East, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 45: Middle East, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 46: Africa, Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 47: Africa, Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 48: AbbVie Inc. Financial Performance Figure 49: Pfizer Inc. Financial Performance Figure 50: Novartis Financial Performance Figure 51: Eli Lilly and Company. Financial Performance Figure 52: Celgene Corporation Financial Performance
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
